These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36751919)

  • 1. Will the New Congress Turn Its Attention to Pharmacy Benefit Managers?
    Baldwin P
    Sr Care Pharm; 2023 Jan; 38(1):41-42. PubMed ID: 36751919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOSPITAL PHARMACY'S RESPONSIBILITIES TO SPONSORS OF INVESTIGATIONAL DRUGS.
    SKOLAUT MW
    Hosp Top; 1965 Aug; 43():91-5. PubMed ID: 14345620
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Pharmacy Benefit Managers on Oncology Practices and Patients.
    Royce TJ; Schenkel C; Kirkwood K; Levit L; Levit K; Kircher S
    JCO Oncol Pract; 2020 May; 16(5):276-284. PubMed ID: 32310720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amazon Pharmacy: distraction or disruption?
    Hohmeier KC; Gatwood J; Boucher B
    Am J Manag Care; 2021 Aug; 27(8):e251-e253. PubMed ID: 34460178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication therapy management services in North Carolina community pharmacies: current practice patterns and projected demand.
    Hansen RA; Roth MT; Brouwer ES; Herndon S; Christensen DB
    J Am Pharm Assoc (2003); 2006; 46(6):700-6. PubMed ID: 17176685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacy Benefit Managers: Impact on Cancer Care Delivery.
    JCO Oncol Pract; 2020 May; 16(5):275. PubMed ID: 32310721
    [No Abstract]   [Full Text] [Related]  

  • 7. Medication synchronization adoption and pharmacy performance.
    Renfro CP; Turner K; Seeto J; Ferreri SP
    Res Social Adm Pharm; 2021 Aug; 17(8):1496-1500. PubMed ID: 33234452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacy Benefit Managers: Do They Provide the Value Promised?
    Mirda DP
    JCO Oncol Pract; 2020 May; 16(5):273-274. PubMed ID: 32396794
    [No Abstract]   [Full Text] [Related]  

  • 9. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
    Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C
    J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy benefit manager reform within Medicaid Managed Care: The pursuit of a model that preserves the intent of the 340B program.
    Almeter PJ; Butler WR; Reynolds JW; Duckworth DL; Labuhn JA; Birdwhistell MD
    Am J Health Syst Pharm; 2022 Sep; 79(18):1607-1611. PubMed ID: 35020794
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018.
    Van Nuys K; Ribero R; Ryan M; Sood N
    JAMA Health Forum; 2021 Nov; 2(11):e213409. PubMed ID: 35977268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of face-to-face educational outreach on diarrhoea treatment in pharmacies.
    Ross-Degnan D; Soumerai SB; Goel PK; Bates J; Makhulo J; Dondi N; Sutoto ; Adi D; Ferraz-Tabor L; Hogan R
    Health Policy Plan; 1996 Sep; 11(3):308-18. PubMed ID: 10160376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with comprehensive medication review completion rates: A national survey of community pharmacists.
    Snyder ME; Jaynes HA; Gernant SA; Lantaff WM; Doucette WR; Hudmon KS; Perkins SM
    Res Social Adm Pharm; 2020 May; 16(5):673-680. PubMed ID: 31439525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coaching strategies for the Flip the Pharmacy practice transformation initiative in Pennsylvania independent community pharmacies.
    Turco E; Carroll JC; McGivney MS; McGrath SH; Herbert SMC; Firm A; Coley KC
    J Am Pharm Assoc (2003); 2023; 63(1):164-168. PubMed ID: 36031545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opinion comparison concerning future information technology in Finnish community pharmacies.
    Westerling AM; Hynninen JT; Haikala VE; Airaksinen MS
    Pharm World Sci; 2010 Dec; 32(6):787-94. PubMed ID: 20848207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negotiating with third party payers: one community pharmacy's experience.
    Fridy K; DeHart RM; Monk-Tutor MR
    J Am Pharm Assoc (Wash); 2002; 42(5):780-8. PubMed ID: 12269712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contribution of the National Academy of Pharmacy of Brazil to the 1st Pan-American Congress of Pharmacy].
    VAILLANT M; GAUTHIER B
    Ann Pharm Fr; 1951 Mar; 9(3):230-7. PubMed ID: 14838444
    [No Abstract]   [Full Text] [Related]  

  • 19. [Direction of the Brazilian National Commission for the Pan-American Pharmacy Congress, at the 4 May session, 1951, of the National Academy of Pharmacy in conjunction with the Federation of Pharmaceutical Societies of Brazil].
    ALBUQUERQUE A
    Rev Quim Farm; 1951 Jun; 16(6):171-9. PubMed ID: 14930432
    [No Abstract]   [Full Text] [Related]  

  • 20. Transitions, part 1: beyond pharmaceutical care.
    Holland RW; Nimmo CM
    Am J Health Syst Pharm; 1999 Sep; 56(17):1758-64. PubMed ID: 10512508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.